Company Overview and News

37
Oil & Gas Stock Roundup: ExxonMobil, Chevron, Transocean & More

2018-06-19 zacks
It was a week where oil prices extended their recent declines but natural gas futures moved above the critical $3 threshold.
XOM EEXXQ VLO MPC EXXI NEE.PRI BHI NEE.PRJ EGC EXXIQ NEE.PRC EXIXQ CVX NEE.PRQ NEE.PRR RIG PAA NEE SGAZF

34
The Daily Drilling Report Recaps The Week That Was

2018-06-19 seekingalpha
We discuss some of the rumblings reaching our ears and make a prognostication on the outcome.
BHI ESV NR RIG

66
Texas and Alaska Witness a Fall in Onshore Drilling Rigs

2018-06-18 zacks
In its weekly release, Baker Hughes (BHGE - Free Report) , a GE company, reported rig count decline in the United States.
DO BHI HD SLB OAS CTLR SCL SLB CLR RIG SGAZF

24
Attempting To Clarify Transocean's Fleet Situation

2018-06-18 seekingalpha
Transocean will "retire in an environmentally responsible way" four floaters from its fleet and take an accompanying $520 million charge in the second quarter.
SMBMF RDS.B S51 RDS.A RYDBF RDSB RDSA RYDAF RIG SMBMY

86
Transocean (RIG) to Retire 4 Rigs, Take Related $520M Charge

2018-06-18 zacks
Transocean Ltd. (RIG - Free Report) recently announced its intention to retire four of its aging rigs —Deepwater Discovery, Deepwater Frontier, Deepwater Millennium and Songa Trym — amid continued offshore weakness. Post the announcement of its decision, the company’s shares have declined more than 3% to eventually close at $11.92 on Jun 15. In regard to this, the oilfield services player will book non-cash impairment charges of around $520 million, which will be reflected in its second-quarter results.
ESV SDRL RIG PES SGAZF

93
Revamping Or Starting A Portfolio Now

2018-06-16 seekingalpha
Old economy, high capital, no moat is a catastrophe waiting to happen - sell your grandpa's stocks.
LMT NE NOBGF SPWR CAT TWX SW GOOG TWC EXAS SWIR ESV GOOGL N21 NOBGY NTR RIG

103
Energy Recap: OPEC Meeting On The Horizon

2018-06-15 seekingalpha
Every Friday, Seeking Alpha provides a roundup of insightful opinion and analysis articles in the energy sector.
CKRGZ CHKVP CHKDH CHKVZ CHKDG CHKWZ BHI CHKDJ CHKDP CHK CHK.WI RIG CHK.PRD

3
RIG / Transocean, Inc. 8-K (Current Report)

2018-06-14 sec.gov
201806_RIG_Form 8-K_Impairment and Rigs Retirement UNITED STATES
RIG

113
Offshore Shipping Market Update

2018-06-12 seekingalpha
Here we will take a look at factors that continue to pave the way for a recovery in the offshore vessel segment.
TOO GLF XOM NAO SFL KNOP ESV TDW GLFMQ SDRL TDW.WSA TDW.WSB RIG BDRLF SGAZF

69
Oil Drilling Rigs Continue to Rise in Permian Basin

2018-06-11 zacks
In its weekly release, Baker Hughes (BHGE - Free Report) , a GE company, reported an increase in rig count in the United States.
APC SLB HSC DO BHI XEL SCL SLB WRD RIG AEUA SGAZF

18
Hedge fund with 69pc return sees more to come from oil recovery

2018-06-11 malaymail
NEW YORK, June 11 — A hedge fund run by a former associate of billionaire John Fredriksen has gained 69 per cent in two years betting on shunned oil-related assets — and it’s not nearly done exploiting the recovery.
ETP.PRC SLB ETP ESV SCL SLB RIG SGAZF

17
Weekly Summary Of The Daily Drilling Report

2018-06-09 seekingalpha
We review the oil company and oil service stocks discussed in the Market Place site this week.
CRR ESV NR TTI RIG

95
Seadrill Will Emerge From Chapter 11 In The First Half Of July

2018-06-08 seekingalpha
In recent months, I’ve been often asked about when Seadrill (SDRL) will emerge from Chapter 11. Prior to June 7, 2018, we only had a vague timeline for this event so such a question could not have been answered. Now, we have an official announcement from the company.
NE ESV NOBGF N21 NOBGY SDRL DTK RIG

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to RIG / Transocean, Inc. on message board site Silicon Investor.

Madrigal Pharmaceuticals Transocean (RIG)
Rigel Pharmaceuticals, Inc. (RIGL) The Supreme Court, All Right or All Wrong?
Political Humor- Left and Right! The American Spirit Vs. The Rightwing
Right Wing Extremist Thread Rigu0027s Platinum Penny Picks
Actual left/right wing discussion Dorsey Wright u0026 Associates. Point and Figure
CUSIP: H8817H100